| 1 |
Singh V, Kaur R, Kumari P, et al. ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders[J]. Clin Chim Acta, 2023, 548: 117487.
|
| 2 |
Qiu Z, Wang Y, Zhang Z, et al. Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications[J]. Front Oncol, 2022, 12: 1052672.
|
| 3 |
Bui TM, Wiesolek HL, Sumagin R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis[J]. J Leukoc Biol, 2020, 108(3): 787-799.
|
| 4 |
Yu J, Liu Y, Peng W, et al. Serum VCAM-1 and ICAM-1 measurement assists for MACE risk estimation in ST-segment elevation myocardial infarction patients[J]. J Clin Lab Anal, 2022, 36(10): e24685.
|
| 5 |
Li Y, Huang Q, Fang M, et al. Prognostic value of serum levels of multiple adhesion factors in patients with sepsis-induced acute kidney injury[J]. Int Urol Nephrol, 2023, 55(5): 1229-1237.
|
| 6 |
Lyck R, Enzmann G. The physiological roles of ICAM-1 and ICAM-2 in neutrophil migration into tissues[J]. Curr Opin Hematol, 2015, 22(1): 53-59.
|
| 7 |
Li N, Yang H, Wang M, et al. Ligand-specific binding forces of LFA-1 and Mac-1 in neutrophil adhesion and crawling[J]. Mol Biol Cell, 2018, 29(4): 408-418.
|
| 8 |
Sulimai N, Brown J, Lominadze D. The effects of fibrinogen's interactions with its neuronal receptors, intercellular adhesion molecule-1 and cellular prion protein[J]. Biomolecules, 2021, 11(9): 1381.
|
| 9 |
Bonan S, Albrengues J, Grasset E, et al. Membrane-bound ICAM-1 contributes to the onset of proinvasive tumor stroma by controlling acto-myosin contractility in carcinoma-associated fibroblasts[J]. Oncotarget, 2017, 8(1): 1304-1320.
|
| 10 |
Dragoni S, Hudson N, Kenny BA, et al. Endothelial MAPKs direct ICAM-1 signaling to divergent inflammatory functions[J]. J Immunol, 2017, 198(10): 4074-4085.
|
| 11 |
Sarelius IH, Glading AJ. Control of vascular permeability by adhesion molecules[J]. Tissue Barriers, 2015, 3(1-2): e985954.
|
| 12 |
Ren X, Manzanares LD, Piccolo EB, et al. Macrophage-endothelial cell crosstalk orchestrates neutrophil recruitment in inflamed mucosa[J]. J Clin Invest, 2023, 133(15): e170733.
|
| 13 |
Wiesolek HL, Bui TM, Lee JJ, et al. Intercellular adhesion molecule 1 functions as an efferocytosis receptor in inflammatory macrophages[J]. Am J Pathol, 2020, 190(4): 874-885.
|
| 14 |
Gu W, Yao L, Li L, et al. ICAM-1 regulates macrophage polarization by suppressing MCP-1 expression via miR-124 upregulation[J]. Oncotarget, 2017, 8(67): 111882-111901.
|
| 15 |
Ding S, Liu J, Han X, et al. ICAM-1-related noncoding RNA accelerates atherosclerosis by amplifying NF-κB signaling[J]. J Mol Cell Cardiol, 2022, 170: 75-86.
|
| 16 |
Puig N, Camps-Renom P, Camacho M, et al. Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke[J]. Transl Stroke Res, 2022, 13(5): 745-756.
|
| 17 |
Varona JF, Ortiz-Regalón R, Sánchez-Vera I, et al. Soluble ICAM 1 and VCAM 1 blood levels alert on subclinical atherosclerosis in non smokers with asymptomatic metabolic syndrome[J]. Arch Med Res, 2019, 50(2): 20-28.
|
| 18 |
陈丽君, 赵文杰, 陈浩, 等. 急性脑梗死血清SIRT1、ICAM-1、PLR与颈动脉粥样硬化斑块的相关性分析[J]. 分子诊断与治疗杂志, 2023, 15(8): 1453-1457.
|
| 19 |
Wang M, Zhang Z, Liu D, et al. Soluble adhesion molecules and functional outcome after ischemic stroke: A Mendelian randomization study[J]. J Stroke Cerebrovasc Dis, 2023, 32(6): 107136.
|
| 20 |
Li C, Hu L, Zhao J, et al. Effect of intravenous thrombolysis combined with mild hypothermia on the levels of IL-1β, IL-6, ICAM-1 and MMP-2 in patients with acute cerebral infarction and clinical significance[J]. Exp Ther Med, 2022, 23(3): 223.
|
| 21 |
Cheng D, Wang Y, Li J, et al. Transcriptomic analysis identifies the S100 calcium-binding protein β subunit (S100B) and intercellular adhesion molecule-1 (ICAM-1) as potential diagnostic biomarkers for acute cerebral infarction[J]. Genes Dis, 2023, 11(1): 46-48.
|
| 22 |
韩晓芳, 邢戈贝利, 李自如, 等. TIA及脑梗死患者血NF-κB、ET-1、ICAM-1水平的变化及临床意义[J]. 内蒙古医学杂志, 2015, 47(6): 652-656.
|
| 23 |
何阳, 黎昌炫, 周艳辉. 血清ICAM-1、LP-PLA2联合ABCD2评分对TIA发作患者短期预后的价值[J]. 脑与神经疾病杂志, 2024, 32(3): 189-192.
|
| 24 |
Wu BN, Wu J, Hao DL, et al. High serum sICAM-1 is correlated with cerebral microbleeds and hemorrhagic transformation in ischemic stroke patients[J]. Br J Neurosurg, 2018, 32(6): 631-636.
|
| 25 |
朱洋洋, 刘梦, 杨道迪, 等. 急性缺血性脑卒中早期脑损伤病人脑脊液ICAM-1、MLKL表达及临床意义[J]. 中西医结合心脑血管病杂志, 2024, 22(3): 561-563.
|
| 26 |
张龙滨. 急性脑梗死溶栓后出血转化患者血清CTRP-3、ICAM-1、TNF-α水平变化及临床意义[J]. 心血管病防治知识, 2022, 12(21): 20-22.
|
| 27 |
Cui Y, Wang XH, Zhao Y, et al. Change of serum biomarkers to post-thrombolytic symptomatic intracranial hemorrhage in stroke[J]. Front Neurol, 2022, 13: 889746.
|
| 28 |
李峥嵘, 袁波, 刘坤, 等. 急性大血管闭塞性脑卒中桥接治疗后再灌注损伤sCD40L、ET-1、ICAM-1因子相关性研究[J]. 脑与神经疾病杂志, 2024, 32(5): 302-306.
|
| 29 |
Zhang X, Zhou F, Wang W, et al. Levels of adhesion molecules and clinical outcomes in patients with ischemic stroke after mechanical thrombectomy[J]. Front Neurol, 2022, 13: 1024162.
|
| 30 |
Hu R, Zhang D, Hu Z, et al. Serum inflammatory cell adhesion molecules predict malignant cerebral edema and clinical outcome early after mechanical thrombectomy in stroke[J]. Clin Neurol Neurosurg, 2022, 223: 107507.
|
| 31 |
王玉霞, 刘英华, 卢海英, 等. 急性冠状动脉综合征患者PCI术前血清ICAM-1、ESM-1水平与术后冠状动脉慢血流/无复流的相关性[J]. 疑难病杂志, 2022, 21(2): 124-129.
|
| 32 |
许丙洋, 袁波, 娄志刚, 等. 急性脑出血患者细胞纤维连接蛋白水平与炎性因子的关系及其对预后预测的价值[J]. 实验与检验医学, 2023, 41(5): 644-646, 655.
|
| 33 |
张云, 焦黛妍, 吴兆华. 血清ICAM-1、MMP-9和Cys-C水平可评估急性脑出血患者的病情和预后[J]. 内科急危重症杂志, 2023, 29(3): 199-202.
|
| 34 |
Witsch J, Roh D, Oh S, et al. Association between soluble intercellular adhesion molecule-1 and intracerebral hemorrhage outcomes in the FAST trial[J]. Stroke, 2023, 54(7): 1726-1734.
|
| 35 |
Hou H, Li X. Clinical changes of serum melatonin and ICAM-1 levels in patients with basal ganglia hypertensive intracerebral hemorrhage[J]. Pak J Med Sci, 2023, 39(4): 1024-1028.
|
| 36 |
Al-Drawi AS, Wiciński M, Grześk G, et al. Evaluation of VCAM-1 and ICAM-1 concentration and values of global tests concerning the coagulation system of patients suffering from subarachnoid haemorrage[J]. Ann Agric Environ Med, 2016, 23(4): 654-659.
|
| 37 |
Huang Q, Wang G, Hu YL, et al. Retraction note: study on the expression and mechanism of inflammatory factors in the brain of rats with cerebral vasospasm[J]. Eur Rev Med Pharmacol Sci, 2024, 28(14): 3969.
|
| 38 |
Rasmussen R, Bache S, Stavngaard T, et al. Plasma levels of IL-6, IL-8, IL-10, ICAM-1, VCAM-1, IFNγ, and TNFα are not associated with delayed cerebral ischemia, cerebral vasospasm, or clinical outcome in patients with subarachnoid hemorrhage[J]. World Neurosurg, 2019, 128: e1131-e1136.
|
| 39 |
Atangana E, Schneider UC, Blecharz K, et al. Intravascular Inflammation Triggers Intracerebral Activated Microglia and Contributes to Secondary Brain Injury After Experimental Subarachnoid Hemorrhage (eSAH)[J]. Transl Stroke Res, 2017, 8(2): 144-156.
|
| 40 |
Bjerkne WS, Odenstedt HH, Svedin P, et al. Association between inflammatory response and outcome after subarachnoid haemorrhage[J]. Acta Neurol Scand, 2021, 143(2): 195-205.
|
| 41 |
江小琳, 杨雪, 程琼, 等. 脑脊液细胞因子水平与动脉瘤性蛛网膜下腔出血后脑血管痉挛的相关性研究[J]. 创伤与急诊电子杂志, 2022, 10(2): 64-72.
|
| 42 |
Guan X, Wang J. Cognitive impairment of MRL mice is related to NMDA receptor-mediated inflammatory response and production of adhesion molecules in MRL/lpr mice-derived micro-vascular endothelial cells[J]. Folia Neuropathol, 2023, 61(1): 25-36.
|
| 43 |
龙晓月, 孟琳, 孙宝莹, 等. 糖调节异常的缺血性脑小血管病患者细胞间黏附分子水平与认知障碍的相关性研究[J]. 中华老年心脑血管病杂志, 2023, 25(6): 572-575.
|
| 44 |
崔昕龙, 张恒海, 田首元. 基于NF-κB/ICAM-1信号通路探究miR-223-3p对大鼠蛛网膜下腔出血早期脑损伤的影响[J]. 卒中与神经疾病, 2023, 30(5): 497-505.
|
| 45 |
Prager B, Spampinato SF, Ransohoff RM. Sphingosine 1-phosphate signaling at the blood-brain barrier[J]. Trends Mol Med, 2015, 21(6): 354-363.
|
| 46 |
Xu D, Gao Q, Wang F, et al. Sphingosine-1-phosphate receptor 3 is implicated in BBB injury via the CCL2-CCR2 axis following acute intracerebral hemorrhage[J]. CNS Neurosci Ther, 2021, 27(6): 674-686.
|
| 47 |
Nakagawa S, Aruga J. Sphingosine 1-Phosphate Signaling Is Involved in Impaired Blood-Brain Barrier Function in Ischemia-Reperfusion Injury[J]. Mol Neurobiol, 2020, 57(3): 1594-1606.
|
| 48 |
Ye X, Peng X, Song Q, et al. Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-κB and ICAM-1 expression[J]. Drug Dev Ind Pharm, 2021, 47(4): 609-617.
|
| 49 |
Hu R, Liang J, Ding L, et al. Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke[J]. Int Immunopharmacol, 2022, 113(Pt A): 109315.
|
| 50 |
Liu X, Xiao G, Wang Y, et al. Qishen Yiqi Dropping Pill facilitates post-stroke recovery of motion and memory loss by modulating ICAM-1-mediated neuroinflammation[J]. Biomed Pharmacother, 2022, 153: 113325.
|